Interv Akut Kardiol. 2005;4(4):203-204

Aortic stenosis. What are the ways to treat it?

Roman Čerbák
Centrum kardiovaskulární a transplantační chirurgie v Brně

Komentář k práci autora Dominik J. Patient-prosthesis mismatch. Interv Akut Kardiol 2005;4:229–232.

Keywords: -

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čerbák R. Aortic stenosis. What are the ways to treat it? Interv Akut Kardiol. 2005;4(4):203-204.
Download citation

References

  1. Rajamannan NM. Is it time for medical therapy for aortic valve diasease? Expert Rev Cardiovasc Ther 2004; 2(6): 845-854. Go to original source... Go to PubMed...
  2. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin-coverting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004; 110(10): 1291-1295. Go to original source... Go to PubMed...
  3. Antonini Canterin F, Popescu BA, Huang G, et al. Progression of aortic valve sclerosis and aortic valve stenosis: what is the role of statin treatment? Ital Heart J 2005; 6(2): 119-124.
  4. Borer JS. Aortic stenosis and statins: more evidence of, ,pleotrophy"? Arterioscler Thromb Vasc Biol 2005; 25(3): 476-477. Go to original source... Go to PubMed...
  5. Peltier M, Enriquez-Sarano M, Slama M, Tribouilloy Ch. New concepts on the physiopathology and therapy of aortic stenosis. Arch Mal Coeur Vaiss 2004; 97(4): 327-332. Go to PubMed...
  6. Podolec P, Kopec G, Rubis P, et al. Calcific and degenerative aortic stenosis-pathogenesis and new possibilities of treatment. Przegl Lek 2004; 61(6): 604-608. Go to PubMed...
  7. Wierzbicky A, Shetty Ch. Aortic stenosis: An atherosclerotic disease? Heart Valve Dis 1999; 8: 416-423.
  8. Cowel SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA. Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid - lowering therapy in calcific aortic stenosis. NEJM 2005; 352(23): 2441-2443. Go to original source... Go to PubMed...
  9. Rossebo A, Pedersen T, Skjaerpe T, at al. Design of the Simvastatin and Ezetimibe in aortic stenosis (SEAS) study. Atherosclerosis 2003; 170(4): 253. Go to original source...
  10. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe" Eur Heart J 2003; 24: 1231-1243. Go to original source... Go to PubMed...
  11. Antonini-Canterin F, Zuppiroli A, Popescu BA, et al. Effect of statins on rhe progression of bioprosthetic aortic valve degeneration. Am J Cardiol 2003; 92(12): 1479-1482. Go to original source... Go to PubMed...
  12. Novaro GM, Griffn BP. Calcific aortic stenosis: another face of atherosclerosis? Cleve Clin J Med 2003; 70(5): 471-477. Go to original source... Go to PubMed...
  13. Chan K-L. Is aortic stenosis a preventable disease? J Am Coll Cardiol 2003; 42: 593-599. Go to original source... Go to PubMed...
  14. Albes JM, Hartrumpf M, Rudolph V, et al. Are mechanical valves with enhanced inner diameter advantageous in the small sized aortic annulus? Ann Thorac Surg 2003; 76(5): 1564-1570. Go to original source... Go to PubMed...
  15. Hanania G, Michel PL, Montely JM, et al. The long term (15 years) evolution after valvular replacement with mechanical prosthesis or bioprosthesis between the age of 60 and 70 years. Arch Mal Coeur Vaiss 2004; 97(1): 7-14.
  16. Ruel M, Kulik A, Rubens FD, et al. Late incidence and determinants of reoperaton in patients with prosthetic heart valves. Eur J Cardiothorax Surg 2004; 25(3): 364-370. Go to original source... Go to PubMed...
  17. Cormier B. Surgical treatment of aortic stenosis: which prosthesis for which patients? Ann Cardiol Angiol 2005; 54(3): 122-126. Go to original source... Go to PubMed...
  18. Maroni JP, Montely JM, Terdjman M, Hanania G. Can bioprostheses be implanted at younger ages? Ann Cardiol Angiol 2004; 53(6): 294-297. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.